ストックスクリーナーアプリを入手
5.19
2.08%
-0.11
プレマーケット:
5.19
前日終値:
$5.30
開ける：
$5.475
24時間の取引高:
29,717
Relative Volume:
0.12
時価総額：
$2.77M
収益：
$1.75M
当期純損益:
$-5.68M
株価収益率:
-1.0651
EPS:
-4.8726
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-8.47%
1か月 パフォーマンス:
-20.76%
6か月 パフォーマンス:
+946.16%
1年 パフォーマンス:
+1,541%
1日の値動き範囲:
$5.06
$5.48
1週間の範囲:
$5.06
$6.085
52週間の値動き範囲:
$0.197
$8.50
Scisparc Ltd Stock (SPRC) Company Profile
SPRC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
5.19 | 2.97M | 1.75M | -5.68M | 0 | -4.8726 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Scisparc Ltd (SPRC) 最新ニュース
Short interest data insights for SciSparc Ltd.Chart Risk Profile for Capital Preservation - Newser
Sentiment analysis tools applied to SciSparc Ltd.High Win Rate Strategy with Stop Protection - Newser
Key metrics from SciSparc Ltd.’s quarterly dataTrade Safety Report with Pattern Insights - Newser
Multi asset correlation models including SciSparc Ltd.Monthly Trade Result and Signal Summary - Newser
What earnings revisions data tells us about SciSparc Ltd.Low Risk Stock Selection Strategy Guide - Newser
Is now a turning point for SciSparc Ltd.Sector-Wise Stock Strength Trend Analysis - Newser
Best data tools to analyze SciSparc Ltd. stockTechnical Trade Plan with Entry Checklist - Newser
Is SQNS stock a buy or sellAggressive Growth Calls - thegnnews.com
Quantitative breakdown of SciSparc Ltd. recent moveAI Generated Buy/Sell Signal Forecast - Newser
Is SciSparc Ltd. forming a bullish divergenceExplosive Profit Potential Today - mustnews.co.kr
SciSparc and Clearmind Publish Patent for Novel Obesity Therapy - TipRanks
Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar - The Manila Times
SciSparc-Clearmind Collaboration Leads to Publication of - GlobeNewswire
Breakthrough Obesity Treatment Patent Targets One-Third of US Adults with Metabolic Syndrome - Stock Titan
SciSparc Ltd. stock chart pattern explainedFree Pattern Alert With ROI Driven Strategy - Newser
Machine Learning Models Forecast SciSparc Ltd. UptickDaily Chart Pattern Stock Forecast Shows Bullish Setup - beatles.ru
AI Trend Models Suggest Bounce for SciSparc Ltd.Community Entry Consensus Trade Ideas Shared - beatles.ru
What catalysts could drive SciSparc Ltd. stock higher in 2025Master the art of timing market moves - Jammu Links News
What is the risk reward ratio of investing in SciSparc Ltd. stockCapitalize on fast-moving stock opportunities - Jammu Links News
How many analysts rate SciSparc Ltd. as a “Buy”Market-leading growth rates - Jammu Links News
How strong is SciSparc Ltd. company’s balance sheetDynamic growth stocks - Jammu Links News
When is SciSparc Ltd. stock expected to show significant growthUnlock powerful insights from market experts - Jammu Links News
What are the technical indicators suggesting about SciSparc Ltd.Tremendous portfolio expansion - Jammu Links News
Why is SciSparc Ltd. stock attracting strong analyst attentionPhenomenal returns - Jammu Links News
How does SciSparc Ltd. compare to its industry peersAchieve consistent profits with expert advice - Jammu Links News
Is it the right time to buy SciSparc Ltd. stockOutperformance with explosive growth - Jammu Links News
What is the dividend policy of SciSparc Ltd. stockBuild wealth steadily with proven stock picks - Jammu Links News
What are the latest earnings results for SciSparc Ltd.High-octane financial growth - Jammu Links News
What drives SciSparc Ltd. stock priceUnlock high-yield investment opportunities - jammulinksnews.com
How volatile is SciSparc Ltd. stock compared to the marketLow Risk Report For Consistent Profits - Jammu Links News
SciSparc Announces Patent Filing and Merger Updates - TipRanks
SciSparc's Proposed Merger with AutoMax Motors Advances with SEC Approval and Shareholder Meetings Scheduled - AInvest
SciSparc regains compliance with Nasdaq’s listing rule - MSN
SciSparc Announces Updates Regarding Proposed Merger; Form - GlobeNewswire
SciSparc sets shareholder vote dates for AutoMax merger By Investing.com - Investing.com Nigeria
SciSparc sets shareholder vote dates for AutoMax merger - Investing.com Australia
SciSparc Secures Critical SEC Approval for Electric Vehicle Merger with AutoMax Motors - Stock Titan
SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC - Taiwan News
SciSparc-Clearmind Collaboration Leads to Filing of - GlobeNewswire
Breakthrough Patent: New Drug Combination Targets 890M Obesity Patients and Fatty Liver Disease - Stock Titan
Moving Average Trends for SciSparc Ltd. Stock: What They IndicateSmart Forecast Signals from AI Models - Newser
Evaluating SciSparc Ltd. with trendline analysisFree Day Trading Signals With High Precision - Newser
What moving averages say about SciSparc Ltd.Free Expert Verified Stock Trade Ideas - Newser
Scisparc Ltd (SPRC) 財務データ
収益
当期純利益
現金流量
EPS
0.24%
3.39%
大文字化:
|
ボリューム (24 時間):